Orgenesis Inc. (ORGS)

0,5873 +0,0069 (+1,19%) A partir del 01:55PM EDT. Mercado abierto.

Orgenesis Inc.

20271 Goldenrod Lane
Germantown, MD 20876
United States
480 659 6404
https://orgenesis.com

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 146

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Ms. Vered Caplan M.Sc.	Chairperson of the Board, CEO & President	341,38k	N/A	1969
Prof. Sarah Ferber Ph.D.	Founder & Chief Scientific Officer	268,32k	N/A	1954
Mr. Victor Miller	CFO, Secretary & Treasurer	N/A	N/A	1970
Pierre Lammeretz	Interim Chief Operating Officer	N/A	N/A	N/A
Dr. Shimon Hassin Ph.D.	Chief Technology Officer	N/A	N/A	N/A
Mr. Joseph Carpinelli	Chief Financial Officer of Octomera	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. The company also provides development services, including regulatory services, pre-clinical studies, intellectual property services, and GMP process translation, as well as support services; hospital services; cell process development services; and distributed cell processing services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.

Gobierno corporativo

El ISS Governance QualityScore de Orgenesis Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.